Silvio E. Inzucchi
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
Papers in
-
- Diabetes Treatment and Management 276
- Diabetes Management and Research 96
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 63
- Diabetes, Cardiovascular Risks, and Lipoproteins 27
-
- Cardiovascular Function and Risk Factors 34
- Heart Failure Treatment and Management 18
- Co-authors
- Bernard Zinman (74 shared papers)Christoph Wanner (60 shared papers)DAVID H. FITCHETT (52 shared papers)Odd Erik Johansen (24 shared papers)John M. Lachin (14 shared papers)Uli C. Broedl (11 shared papers)Michaela Mattheus (33 shared papers)Stefan Hantel (19 shared papers)
- Journals
- Diabetes Care (66 papers)Circulation (40 papers)Journal of the American College of Cardiology (28 papers)European Journal of Heart Failure (26 papers)Diabetes Obesity and Metabolism (23 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Silvio E. Inzucchi
520 papers receiving 62.4k citations
Silvio E. Inzucchi's Hit Papers
Peers
Comparison fields: 5 of 178
- Endocrinology, Diabetes and Metabolism 39.2k
- Cardiology and Cardiovascular Medicine 12.5k
- Nephrology 3.1k
- Surgery 11.7k
- Pharmacology 3.3k
Countries citing papers authored by Silvio E. Inzucchi
This map shows the geographic impact of Silvio E. Inzucchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvio E. Inzucchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvio E. Inzucchi more than expected).
Fields of papers citing papers by Silvio E. Inzucchi
This network shows the impact of papers produced by Silvio E. Inzucchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvio E. Inzucchi. The network helps show where Silvio E. Inzucchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Silvio E. Inzucchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 541 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes Hit paper breakdown → | 2015 | 9417 |
| 2 | Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Hit paper breakdown → | 2019 | 5176 |
| 3 | Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Hit paper breakdown → | 2016 | 2917 |
| 4 | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach Hit paper breakdown → | 2012 | 2789 |
| 5 | Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes Hit paper breakdown → | 2014 | 2549 |
| 6 | Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction Hit paper breakdown → | 2022 | 1922 |
| 7 | American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control Hit paper breakdown → | 2009 | 1069 |
| 8 | Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease Hit paper breakdown → | 2020 | 932 |
| 9 | Mechanism by which metformin reduces glucose production in type 2 diabetes. Hit paper breakdown → | 2000 | 895 |
| 10 | Oral Antihyperglycemic Therapy for Type 2 Diabetes Hit paper breakdown → | 2002 | 895 |
| 11 | Pioglitazone after Ischemic Stroke or Transient Ischemic Attack Hit paper breakdown → | 2016 | 888 |
| 12 | How Do We Define Cure of Diabetes? Hit paper breakdown → | 2009 | 814 |
| 13 | Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME ® trial Hit paper breakdown → | 2016 | 775 |
| 14 | Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials Hit paper breakdown → | 2022 | 747 |
| 15 | Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus Hit paper breakdown → | 1998 | 674 |
| 16 | SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials Hit paper breakdown → | 2022 | 668 |
| 17 | Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects Hit paper breakdown → | 2004 | 610 |
| 18 | Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes Hit paper breakdown → | 2009 | 607 |
| 19 | How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial Hit paper breakdown → | 2017 | 599 |
| 20 | Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes Hit paper breakdown → | 2015 | 584 |
About Silvio E. Inzucchi
Silvio E. Inzucchi is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Nephrology and Molecular Biology, having authored 541 papers that have together received 65.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (276 papers), Diabetes Management and Research (96 papers), Metabolism, Diabetes, and Cancer (76 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (63 papers), Pancreatic function and diabetes (53 papers), Cardiovascular Function and Risk Factors (34 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (27 papers) and Heart Failure Treatment and Management (18 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (39.2k citations), Cardiology and Cardiovascular Medicine (12.5k citations), Nephrology (3.1k citations), Surgery (11.7k citations) and Pharmacology (3.3k citations). Silvio E. Inzucchi has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Bernard Zinman, Christoph Wanner, DAVID H. FITCHETT, Odd Erik Johansen, John M. Lachin, Uli C. Broedl, Michaela Mattheus, Stefan Hantel, Hans Jurgen Woerle and Erich Bluhmki. Their work appears in journals such as Diabetes Care, Circulation, Journal of the American College of Cardiology, European Journal of Heart Failure and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.